• Zyversa Therapeutics shifted its trading venue effective July 16, 2026.
• Trading ceased on the OTCQB Venture Market.
• Shares began trading on the OTC Pink Limited Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zyversa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033565), on July 16, 2026, and is solely responsible for the information contained therein.